Head-to-head dispatch
AM Rx vs PlushCare
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
AM Rx (getamrx.com) is a telehealth platform operated by FitRX, LLC (also operates Zealthy and FitRx).
Marked down on: Active FTC/DOJ lawsuit over deceptive billing and subscription practices
FDAWarning letter issued to FitRX, LLC dba AM RX in June 2026. See the FDA warning-letter database.
Desk Score
Established virtual primary-care telehealth platform (subsidiary of Transcarent, Inc., a Delaware corporation, alongside Accolade, 2nd.MD, and 98point6 by Transcarent).
Marked down on: Facing a California class action alleging deceptive subscription enrollment and unauthorized charges after cancellation
PlushCare takes this head-to-head with the higher Desk Score, 73/100 (C) against 40/100 (C) for AM Rx. AM Rx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
AM Rx
40/100
C
PlushCare
73/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | AM Rx | PlushCare |
|---|---|---|
| Semaglutide | $151/mo (quarterly plan, plus a separate fee, compounded) | $149/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | $399/mo (starting dose, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | Patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully). | Readers who want virtual primary care that can also prescribe GLP-1s. |
| Desk Score | 40/100C | 73/100C |
The verdict
Desk pick — PlushCarePlushCare takes this head-to-head with the higher Desk Score, 73/100 (C) against 40/100 (C) for AM Rx. AM Rx still holds its ground where its strengths line up with yours.
Choose AM Rx if…
Patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully).
$151/mo (quarterly plan, plus a separate fee, compounded) sema · Not disclosed tirz · Coverage not published
FDAWarning letter issued to FitRX, LLC dba AM RX in June 2026. See the FDA warning-letter database.
Choose PlushCare if…
Readers who want virtual primary care that can also prescribe GLP-1s.
$149/mo (starting dose, compounded) sema · $399/mo (starting dose, compounded) tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: AM Rx · PlushCare.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- AM Rx vs CoreAge Rx
- PlushCare vs Vaylen
- AM Rx vs Strut Health
- PlushCare vs Ondra Health
- AM Rx vs Invigor Medical
- PlushCare vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.